← Back
$KALV All transactions

KalVista Pharmaceuticals, Inc.

M

$ Value

Shares

3,750

Price

Filed

Aug 25

Insider

Name

Yea Christopher

Title

CHIEF DEVELOPMENT OFFICER

CIK

0001691102

Roles

Officer

Transaction Details

Transaction Date

2025-08-21

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

133,243

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | 1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025, subject to continued service through each vesting date.

Filing Info

Accession No.

0001415889-25-022968

Form Type

4

Issuer CIK

0001348911

Yea Christopher's History

Date Ticker Type Value
2025-08-25 KALV $26K
2025-08-22 KALV $31K
2025-08-22 KALV M
2025-08-22 KALV M $0
2025-08-21 KALV M
2025-08-21 KALV M $0
2025-08-18 KALV $35K
2025-08-17 KALV M
2025-08-17 KALV M $0
2025-08-17 KALV M $0

Other Insiders at KALV (90d)

Insider Bought Sold Last
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
$193K 2026-04-17
Venrock Healthcare Capital Partners III, L.P. $3.7M 2026-03-26
Piekos Brian
Chief Financial Officer
2026-04-16
Piekos Brian / Sweeny Nicole
Chief Financial Officer
$38K 2026-04-17
Sweeny Nicole
Chief Commercial Officer
2026-04-16
Audhya Paul K.
CHIEF MEDICAL OFFICER
$54K 2026-04-17